
According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.59 million. In Q3, DarioHealth brought in $5.63 million in sales but lost $22.44 million in earnings.